mRNA Vaccine Builds Virus-Like Nanoparticles Inside the Body
A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is exploring a new approach to COVID vaccines: using mRNA to let the body assemble its own virus-like particles.
The self-assembling system produces higher antibody levels in mice than conventional COVID-19 vaccines, according to research led by King.
The latest chemistry news, including important research advances, business and policy trends, chemical safety practices, career guidance, and more.
Author's summary: mRNA vaccine produces higher antibody levels.